Yi-Chien Liu
Overview
Explore the profile of Yi-Chien Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liu Y, Lo Y, Peng H, Song C
Geriatr Nurs
. 2023 Aug;
53:162-169.
PMID: 37540911
Objectives: To investigate the effectiveness of family caregiver-administered home-based manual massages in managing dementia symptoms and reducing caregiver stress. Methods: Thirty-eight pairs of participants-patients with dementia and their family caregivers-were...
12.
Fan K, Lin C, Liu Y, Chao Y, Lai Y, Chiu Y, et al.
Front Aging Neurosci
. 2023 Jun;
15:1162057.
PMID: 37346147
Introduction: The microbiota-gut-brain axis is implicated in Alzheimer's disease. Gut microbiota alterations in mild cognitive impairment (MCI) are inconsistent and remain to be understood. This study aims to investigate the...
13.
Lee L, Wu S, Ho C, Liang W, Liu Y, Chou C
PLoS One
. 2023 Mar;
18(3):e0283790.
PMID: 37000849
Background: Acetylcholinesterase inhibitor (AChEI) drug regimens are the mainstay treatment options for patients with Alzheimer's disease (AD). Herein, We examined the association between clinical response to AChEI and white matter...
14.
Chiang K, Chiu Y, Yar N, Chen Y, Cheng C, Liu Y, et al.
Int J Mol Sci
. 2023 Mar;
24(5).
PMID: 36901874
Diabetes nephropathy (DN) is one of the most common causes of end stage renal disease (ESRD) globally. Medication options to stop or slow the progression of chronic renal disease (CKD)...
15.
Yu M, Chuang Y, Wu S, Ho C, Liu Y, Chou C
Front Neurol
. 2023 Mar;
14:1100322.
PMID: 36864910
Background And Objectives: Among individuals with Alzheimer's disease (AD), e4 carriers with increased white matter hyperintensities (WMHs) may selectively be at increased risk of cognitive impairment. Given that the cholinergic...
16.
Liu Y, Liao C, Song C
Geriatr Nurs
. 2022 Jun;
46:112-117.
PMID: 35662019
Objectives: To explore the effects of a 10-week manual massage intervention given by caregivers of patients with dementia on the behavioral and psychological symptoms of dementia (BPSD) and caregiver burden....
17.
Tsai C, Huang M, Cheng C, Lee J, Wang W, Huang L, et al.
Int J Geriatr Psychiatry
. 2022 Apr;
37(5).
PMID: 35437817
Background: This study investigated the determinants and use of Taiwan's long-term care (LTC) Plan Version 2.0 (LTC 2.0) services by persons with dementia (PWDs) and their caregivers. Methods: In total,...
18.
Tsai C, Huang M, Lee J, Jhang K, Huang L, Huang L, et al.
J Chin Med Assoc
. 2022 Mar;
85(4):462-468.
PMID: 35286289
Background: There is a dearth of information on male dementia caregivers in Asia and, in particular, on the factors relating to caregiver burden. We aimed to identify factors that may...
19.
Chen L, Liu Y
Int J Environ Res Public Health
. 2022 Feb;
19(4).
PMID: 35206653
The aim of this study is to investigate the problems and needs of users with advanced age and cognitive impairment regarding the design and operation of daily living products. Television...
20.
Lee L, Yip P, Fan Y, Liu Y
Acta Neurol Taiwan
. 2022 Jan;
PMID: 35040111
Purpose Alzheimer disease (AD) is an irreversible neurodegenerative disease that causes progressive cognitive decline. Co-existing thymoma should be considered when rapid deterioration of cognition was noted in AD patients and...